Agilent and the National Jewish Medical and Research Center to Offer Systems Biology Training
News Jul 19, 2007
Agilent Technologies and the National Jewish Medical and Research Center have announced a collaborative effort to provide applications-focused technical training in the fast-emerging field of systems biology.
The alliance unites Agilent’s comprehensive suite of solutions for proteomics, genomics and metabolomics with the scientific and diagnostic expertise of scientists at the nation’s respiratory hospital.
Nichole Reisdorph, Ph.D., assistant professor of immunology and director of the National Jewish mass spectrometry facility, leads the training programs, which include e-seminars over the Web, hands-on application training and classroom instruction.
Dr. Reisdorph has trained more than 150 scientists and conducted nearly 20 workshops in the past three years, including a recent 10-day genomics and proteomics workshop funded by the National Institutes of Health’s Heart, Lung and Blood Institute. Dr. Reisdorph’s expertise in “omics” technologies contributes to National Jewish’s integration of basic and clinical science to develop pioneering personalized medicine programs.
The courses, which are open to the public, include the new “Hands-on Metabolomics and Proteomics Workshop” (Aug. 27-31) as well as database-searching and clinical-proteomics programs, among many others. Information about the National Jewish’s growing curriculum of novice, intermediate and advanced courses is available at www.systemsbiologytraining.org.
The center’s teaching lab, which opened in late May, is equipped with an array of Agilent instruments and software, including:
• 6410 Triple Quadrupole Liquid Chromatography/Mass Spectrometer (LC/MS);
• 6510 Quadrupole Time-of-Flight (Q-TOF) LC/MS, with HPLC Chip technology;
• 6210 TOF LC/MS with electrospray ionization;
• 6340 Ion Trap LC/MS with HPLC Chip technology;
• Several Agilent 1200 Series HPLCs, including the Rapid Resolution LC system;
• Agilent 2100 Bioanalyzer;
• Agilent DNA Microarray Scanner with analysis software;
• GeneSpring GX and GeneSpring MS software for statistical analysis of array and mass spectrometry data;
• SpectrumMill software for analysis of peptides and proteins; and
• Proteomics LC columns, including macroporous reverse phase columns for separating intact proteins and MARS immunodepletion columns for isolation of plasma proteins.
“Agilent’s integrated collection of mass spectrometers, DNA microarrays and informatics software allows us to teach coherent, comprehensive ‘omics’ techniques in our lab,” explained Dr. Reisdorph. “This collaboration allows our students to focus on systems biology questions and on the amazing answers that are now available via modern tools and techniques, without having to combine disjointed platforms from many vendors.”
“Scientists entering the systems biology field have few opportunities to receive focused, hands-on training,” said Agilent’s Nick Roelofs, vice president and general manager, Life Sciences Solutions. “We’re proud to be a part of this important collaboration, which provides researchers across all disciplines with access to state-of-the-art instrumentation, cutting-edge workflows and tremendous instructional expertise from academic and clinical scientists.”
Lake gives Clues to Earth's Ancient AtmosphereNews
A sample of ancient oxygen, teased out of a 1.4 billion-year-old evaporative lake deposit in Ontario, provides fresh evidence of what the Earth’s atmosphere and biosphere were like during the interval leading up to the emergence of animal life.READ MORE
Big Data Study Targets Genomic Dark Matter from Ocean Floor to Gut FloraNews
An international team led by computational biologist Fran Supek at IRB Barcelona develop a machine learning method to predict unknown gene functions of microbes.The system examines and compares ‘big data’ available on the metagenomes of human and environmental microbiomes.READ MORE
A Mechanism of Drug Resistance in Breast & Ovarian CancerNews
Researchers have discovered the molecular means by which some cancers caused by errors in the gene BRCA1 evade treatment by drugs custom-tailored to kill them.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018